In collaboration with Qatar BioBank, Hamad Medical Corporation (HMC), represented by the Department of Laboratory Medicine and Pathology (DLMP), has begun the first phase of the Tissue Biobank Service in Qatar (QBB).
The procedure of gathering, processing, storing, and dispersing human tissue samples for research is known as tissue biobanking. These tissue samples, which are obtained from extra tissue left over following surgeries or biopsies, are used to examine a variety of illnesses and medical disorders. By studying tissue samples, researchers may better understand how illnesses arise and advance and they can find possible targets for novel therapies. It enables researchers to examine diseases and health situations at the cellular and molecular level. Chairperson of Department of Laboratory Medicine and Pathology at HMC Dr. Einas Al Kuwari said: “The launch of the program is an exciting achievement and the result of the strong and long-lasting partnership between the two organizations, pointing out that the implications of this feat are numerous and substantive as more than 300,000 diverse surgical pathology samples from 2008 and up to date will be at the disposal of the researchers, and will inevitably lead to further advancement in medicine.”